13th Chamber LLC has completed 63 quantum computing jobs on IBM’s ibm_torino 133-qubit processor, applying quantum molecular simulation to cancer drug discovery.
Using the proprietary QSAM encoding framework, the system screens 59 FDA-approved compounds across 29 cancer types, achieving a 12.4x quantum advantage over classical screening methods. FOLFIRINOX chemotherapy optimization is among the active research applications.
Research contact: josephdougherty483@gmail.com
© 2026 Joseph C. Dougherty Jr. | 13th Chamber LLC. All rights reserved. Patent Pending. ORCID: 0000-0002-3161-1379.
13th Chamber LLC: Quantum Innovation 